| 1Bendroflumethazide |
|---|
| 2Bendroflumethazide |
Compound Name Bendrofluazide |
CID 2315 |
Molecular Formula C15H14F3N3O4S2 |
Molecular Weight 421 |
No. Chiral Centers: 1 |
No. Hydrogen Bond Acceptors 10 |
No. Hydrogen Bond Donors 3 |
Applications
Bendroflumethazide
13587
Separation Mode: Chiral
Chiral
3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine
HPLC
Antihypertensive Agents
Pharmaceutical
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 13587)
Column: | ||||||
Brand Name: | ||||||
Part No: | ||||||
Phase Name: 3020 (S)-tert-leucine and (R)-1-(alpha-naphthyl)ethylamine | ||||||
Elution Type: Isocratic | ||||||
Mobile Phase: A: Hexane/Dichloroethane/Ethanol-TFA (58:35:7) w/ethanol-TFA (20:1) | ||||||
Gradient Profile:
| ||||||
Flow Rate: 1 mL/min | ||||||
Temperature: 22°C | ||||||
Detection: UV-Vis Abs.-Variable Wave.(UV) @ 272 nm (22°C) |
Order Items Used in This Application
00G-3020-E0
Chirex (S)-LEU and (R)-NEA, LC Column 250 x 4.6 mm, Ea
Qty:
Similar Applications
search
Bendroflumethazide
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
